Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

Bubs (ASX:BUB) Shares Jump With Big New Partnership

The Bubs Australia Ltd (ASX: BUB) share price has jumped over 6% this morning in response to a key partnership it has made.

Bubs was founded in 2006 by Kristy Carr and was listed on the ASX in January 2017. Its infant formula is based on goat milk and it also sells organic baby food. Bubs recently acquired NuLac Foods, Australia’s largest producer of goat milk products, it also guarantees exclusive supply of local goat milk from Australia’s largest herd of milking goats.

Bubs’ Big New Partnership

Bubs has entered into a strategic equity-linked alliance with Chemist Warehouse.

A binding heads of agreement has been signed with Chemist Warehouse Retail Group to create a four-year alliance for the sale and promotion of Bubs products in Chemist Warehouse stores, commencing on 1 June 2019.

There will be 28 Bubs products on Chemist Warehouse shelves nationally. It’s the largest pharmacy chain network by total sales, with over 450 franchised stores across Australia and New Zealand under the Chemist Warehouse and My Chemist names.

Bubs mentioned that Chemist Warehouse also acts as a gateway to China for Australian brands with Chinese residents and tourists transporting back health and infant nutrition products.

A limited number of Bubs products have already been sold in Chemist Warehouse for some time, but the success of online sales and the quality of the Bubs range encouraged the two partners to make this agreement.

The Bubs products will be sold on Chemist Warehouse’s domestic and Tmall online stores.

The Strategic Partnership

Chemist Warehouse is to provide sales and marketing services for a fee, linked to sales performance targets.

With the marketing fee that Bubs is paying to Chemist Warehouse, the pharmacy business is using that to invest in Bubs shares. It will be an initial 12.36 million shares and a maximum of around 37 million shares.

Bubs Founder and CEO Kristy Carr said: “We firmly believe this transaction will deliver strong growth in Bubs’ business, as well as offer significant long-term shareholder value.

Now, with our key partners in place and a fully vertically integrated business with milk pool security and ownership of our manufacturing facility, we are set for rapid global expansion.”

This is certainly another exciting announcement by Bubs, it is proving to be one share to watch. Ms Carr said it well, the foundations are there for a good amount of growth over the coming years, although it’s definitely not guaranteed.

There is a lot of competition in the infant formula space, so the ASX growth shares revealed in the free report below could be more likely to deliver market beating returns than Bubs.

At the time of publishing, Jaz does not have a financial interest in any of the companies mentioned.

Are you stuck wondering where to invest right now? Have you got cash 'sitting on the sidelines'? Are you looking for dividend income AND growth but don't know where to start? Rask's expert ASX analyst team has just released a full report, detailing where we'd invest $10,000 right now.

Not only are we offering these 11 investment ideas completely FREE, we've also released an in-depth podcast to go with the report!

So, whether you have $2,000 or $50,000, our brand new analyst report could help transform your watchlist. Right now, you can get the full analyst report emailed to you for FREE by CLICKING HERE NOW or simply entering your email below.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Are you stuck wondering where to invest right now? Have you got cash 'sitting on the sidelines'? Are you looking for dividend income AND growth but don't know where to start? Rask's expert ASX analyst team has just released a full report, detailing where we'd invest $10,000 right now.

Not only are we offering these 11 investment ideas completely FREE, we've also released an in-depth podcast to go with the report!

So, whether you have $2,000 or $50,000, our brand new analyst report could help transform your watchlist. Right now, you can get the full analyst report emailed to you for FREE by CLICKING HERE NOW.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

LIVE ASX Chat - Join in!

Play Video

Keep reading:

Rask Analyst’s $10,000 Hypothetical Portfolio 

Rask Australia’s expert analysts have just released 11 stock & ETF positions they’d buy right now as part of a $10,000 hypothetical portfolio. 

Completely free, this report comes with the exact ticker codes, how much the analysts would invest and a detailed over the company and why we like it. Plus a 60-min podcast! 

Simply enter your email address and we’ll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.